A landmark deal has placed Australian vaccine innovation on the world stage and CMM has provided integral expertise and infrastructure to help deliver manufacturing, process development and analytical testing to support the translation of research discovery towards clinical trials.
Invented by Professor Keith Chappell, Professor Daniel Watterson and Emeritus Professor Paul Young, the Molecular Clamp platform allows researchers to stabilise viral proteins in a shape that better triggers the immune system. It first came to global attention during the COVID-19 pandemic through UQ’s partnership with the Coalition for Epidemic Preparedness Innovations (CEPI).
A few statements from the lead Scientists:
Professor Dan Watterson
Thanks to Roger and the CMM team for the support over years, visualizing what we were making was not only important to the science but was also integral to getting funding/investment for the platform.
Professor Keith Chappell
Fully agree with Dan. The growing collection of structures confirming the quality of the vaccines we've produced is extremely important to the various pitch slides we've presented at all stages. Big thanks to the CMM team.
Emeritus Professor Paul Young
The structural component of the work was integral. Thank you for your support.
